Synopsys Total Cost of Revenue decreased by 2.6% to $637.38M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 136.1%, from $269.98M to $637.38M. Over 4 years (FY 2021 to FY 2025), Total Cost of Revenue shows an upward trend with a 17.2% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
An increase relative to revenue suggests rising production costs or margin compression, while a decrease suggests improved operational efficiency.
Total cost of revenue includes the direct costs attributable to the production of goods or the delivery of services sold...
Varies by industry; for medical device manufacturers, this includes significant manufacturing and supply chain costs.
total_cost_of_revenue| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $213.99M | $205.07M | $234.73M | $256.98M | $252.81M | $271.18M | $117.04M | $284.35M | $248.24M | $260.43M | $286.18M | $279.19M | $300.40M | $290.68M | $375.02M | $269.98M | $318.35M | $380.56M | $654.66M | $637.38M |
| QoQ Change | — | -4.2% | +14.5% | +9.5% | -1.6% | +7.3% | -56.8% | +143.0% | -12.7% | +4.9% | +9.9% | -2.4% | +7.6% | -3.2% | +29.0% | -28.0% | +17.9% | +19.5% | +72.0% | -2.6% |
| YoY Change | — | — | — | — | +18.1% | +32.2% | -50.1% | +10.7% | -1.8% | -4.0% | +144.5% | -1.8% | +21.0% | +11.6% | +31.0% | -3.3% | +6.0% | +30.9% | +74.6% | +136.1% |
| Segment | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Maintenance and service | $88.18M | $96.63M | $91.71M | $92.54M | $94.47M | $103.30M | $154.22M | $146.74M |
| Products | $198.72M | $179.54M | $216.49M | $168.84M | — | — | — | — |
| Total | $300.40M | $290.68M | $375.02M | $269.98M | $318.35M | $380.56M | $654.66M | $637.38M |